HairDX Hair Loss Test Now Sold In Japan

It’s been just about a year since we first reported on HairDX, the breakthrough DNA test that looks for a genetic variant found in most bald men. HairDX has certainly helped American hair loss sufferers make better, more informed choices when considering treating their hair loss. As of this month, Japanese men and women will be able to test for their genetic predisposition for hair loss as well.

PharmaGenoma, Inc., is the first company ever to introduce a test of this kind. The company announced its exclusive agreement with Aderans Company Limited of Tokyo. This breakthrough test will be available March 1, 2009 in Japan and sold as a HairDX test collection kit. The kit is listed with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) as a Class 1 medical device.

The simple and accurate genetic test provides clear information that is easy to understand. HairDX analyzes the likelihood of a man or woman developing Androgenetic Alopecia, the most common type of hair loss.

 “Aderans partnership with HairDX will allow people in Japan to learn their risk for hair loss early, so they can choose the best treatment to preserve their hair,” says Katsuji Tokumaru, President of Aderans Co. Ltd.

About HairDX, LLC

HairDX, LLC is a subsidiary of PharmaGenoma, Inc. Based in Irvine, CA, USA. HairDX is a molecular dermatology research and development company. HairDX markets the first genetic test for male and female hair loss. The company is dedicated to the research and development of new prescription based therapies tailored to an individual’s genetic make up. HairDX uses only CLIA certified laboratories (Clinical Laboratory Improvement Amendments) to perform the genetic analysis. The HairDX test collection kit is listed with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and the United States Food and Drug Administration (FDA) as a Class I medical device.

Among HairDX leaders is William V. Murray former Division President of the Molecular Biology Division of Applied BioSystems, Inc., who formerly served in various executive leadership positions within Medtronic, Inc., Andy Goren former CEO of MobileWise, Inc. and GeePS, Inc., Professor Doron Lancet, PhD, Head of the Crown Human Genome Center at the Department of Molecular Genetics, Weizmann Institute of Science, Dr. Elon Pras, Director of the Institute of Human Genetics, Sheba Medical Center in Tel-Hashomer, Israel, Sharon Keene, MD, IAHRS Member and President and Medical Director of Physician’s Hair Institute, in Tucson, Arizona, Elliott J. Stein, an intellectual property attorney and co-founder of GeePS, Inc., and Spencer David Kobren, international best selling author and founder of The American Hair Loss Association.

 

Tags: , , ,

No Comments

Your email address will not be published. Required fields are marked *

 

 

 
 

Subscribe

Enter your email address:

 
 

"Spencer Kobren's nationally syndicated show "The Bald Truth" has a dedicated listenership that would have Rush Limbaugh pulling his hair out in envy." --Pittsburgh Tribune-Review.

 
 
 
 
 

BaldTruthTalk Forums

 
 

Talk

 
 
 
 
 
 

News